| Index | — | P/E | 11.90 | EPS (ttm) | 1.01 | Insider Own | 46.10% | Shs Outstand | 17.60M | Perf Week | -2.04% |
| Market Cap | 211.50M | Forward P/E | 10.32 | EPS next Y | 1.16 | Insider Trans | 1.55% | Shs Float | 16.51M | Perf Month | -3.45% |
| Enterprise Value | 145.50M | PEG | 1.60 | EPS next Q | 0.25 | Short Float | 5.56% | Perf Quarter | -41.25% | ||
| Income | 18.00M | P/S | 0.43 | EPS this Y | -8.08% | Short Ratio | 5.64 | Perf Half Y | -53.82% | ||
| Sales | 492.00M | P/B | 1.25 | EPS next Y | 10.13% | ROA | 6.97% | Short Interest | 918.67K | Perf YTD | -44.30% |
| Book/sh | 9.60 | P/C | 2.55 | EPS next 5Y | 7.43% | ROE | 11.00% | 52W High | 28.14 -57.29% | Perf Year | -8.52% |
| Cash/sh | 4.72 | P/FCF | 11.13 | EPS past 3/5Y | — -0.19% | ROIC | 9.78% | 52W Low | 11.93 0.80% | Perf 3Y | -30.56% |
| Dividend Est. | — | EV/EBITDA | 3.46 | Sales past 3/5Y | 4.39% 4.51% | Gross Margin | 73.16% | Volatility | 3.01% 3.00% | Perf 5Y | -24.97% |
| Dividend TTM | — | EV/Sales | 0.30 | EPS Y/Y TTM | 35.94% | Oper. Margin | 5.96% | ATR (14) | 0.39 | Perf 10Y | -17.95% |
| Dividend Ex-Date | Mar 26, 2021 | Quick Ratio | 1.55 | Sales Y/Y TTM | 6.72% | Profit Margin | 3.68% | RSI (14) | 31.82 | Recom | 2.50 |
| Dividend Gr. 3/5Y | — 20.11% | Current Ratio | 2.60 | EPS Q/Q | -40.00% | SMA20 | -3.62% | Beta | 0.81 | Target Price | 31.00 |
| Payout | 0.00% | Debt/Eq | 0.10 | Sales Q/Q | 1.74% | SMA50 | -7.74% | Rel Volume | 0.87 | Prev Close | 12.25 |
| Employees | 806 | LT Debt/Eq | 0.10 | Earnings | Nov 04 | SMA200 | -41.37% | Avg Volume | 160.87K | Price | 12.02 |
| IPO Date | Jun 25, 2009 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -22.22% -5.43% | Net Debt/EBITDA | -1.57 | Volume | 140,684 | Change | -1.88% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-10-26 | Reiterated | DA Davidson | Buy | $21 → $25 |
| May-08-26 | Reiterated | Canaccord Genuity | Buy | $33 → $37 |
| Oct-21-25 | Reiterated | D.A. Davidson | Buy | $21 |
| Sep-13-24 | Reiterated | Canaccord Genuity | $18 |
Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that primarily manufactures and distributes a wide array of nutritional supplements and personal care products. The company's operational reach spans several continents, including Asia, Europe, North America, and Latin America. Its comprehensive nutritional offerings cater to general well-being, providing support for blood sugar regulation, bone density, cellular vitality, cognitive sharpness, joint mobility, mood balance, sexual wellness, sleep quality, athletic performance, and visual acuity. Additionally, it supplies specialized products for immune support, cardiovascular health, and digestive function, alongside solutions for weight management. In the personal care segment, their product line includes items such as essential oils and lotions, aloe vera gels, botanical shampoos, herbal skin treatments, dental care products like toothpaste, and skin cleansing formulations. These goods are sold under the company's proprietary Nature's Sunshine and Synergy WorldWide brands, primarily through an extensive network of independent sales consultants. Established in 1972, the organization is headquartered in Lehi, Utah.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 492 | 480 | 454 | 445 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 132 | 132 | 130 | 124 | — | — | — | — | — | |
| Gross Profit | 360 | 348 | 325 | 321 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 294 | 323 | 305 | 302 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 2 | 0 | — | — | — | — | — | |
| Other Operating Expense | 36 | 0 | -2 | 0 | — | — | — | — | — | |
| Operating Income | 29 | 25 | 20 | 19 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 5 | -2 | 2 | — | — | — | — | — | |
| Net Income Before Taxes | 28 | 30 | 18 | 20 | — | — | — | — | — | |
| Income Taxes | 10 | 9 | 11 | 4 | — | — | — | — | — | |
| Consolidated Net Income | 18 | 20 | 8 | 15 | — | — | — | — | — | |
| Net Income From Continuing Operations | 20 | 20 | 8 | 16 | — | — | — | — | — | |
| Net Income | 18 | 20 | 8 | 15 | — | — | — | — | — | |
| EPS (Recurring) | 1.02 | 1.08 | 0.41 | 0.79 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.02 | 1.08 | 0.41 | 0.79 | — | — | — | — | — | |
| EPS (Diluted) | 1.01 | 1.06 | 0.40 | 0.77 | — | — | — | — | — | |
| EBITDA | 42 | 44 | 33 | 32 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 11.90 | 20.36 | 36.65 | 22.45 | — | — | — | — | — | |
| Price To Sales Ratio | 0.44 | 0.81 | 0.61 | 0.74 | — | — | — | — | — | |
| Gross Margin | 73.17 | 72.50 | 71.59 | 72.13 | — | — | — | — | — | |
| Operating Margin | 5.89 | 5.21 | 4.41 | 4.27 | — | — | — | — | — | |
| Net Margin | 3.66 | 4.17 | 1.76 | 3.37 | — | — | — | — | — | |
| Shares Outstanding | 18 | 18 | 19 | 19 | — | — | — | — | — | |
| Market Capitalization | 216 | 388 | 279 | 329 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Aug 17 '26 | Buy | 14.69 | 20,000 | 293,800 | 1,944,486 | Aug 19 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Aug 10 '26 | Buy | 15.84 | 40,876 | 647,539 | 1,924,486 | Aug 10 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Aug 07 '26 | Buy | 16.63 | 96,000 | 1,596,580 | 1,883,610 | Aug 10 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Aug 06 '26 | Buy | 16.57 | 4,513 | 74,793 | 1,787,610 | Aug 10 |
| Herbert Kevin R. | EVP & President, North America | Jun 12 '26 | Sale | 20.68 | 2,000 | 41,364 | 48,866 | Jun 15 |
| Yates Bryant J | EVP & President, Europe | Jun 05 '26 | Sale | 19.90 | 11,968 | 238,163 | 77,446 | Jun 11 |
| Norman Daniel C | EVP & President, Asia | Jun 01 '26 | Sale | 20.64 | 9,713 | 200,476 | 47,276 | Jun 03 |
| Brower Nathan G | EVP, General Counsel | May 21 '26 | Sale | 21.84 | 12,015 | 262,408 | 43,438 | May 22 |
| Brower Nathan G | EVP, General Counsel | May 05 '26 | Option Exercise | 0.00 | 5,775 | 0 | 46,893 | May 07 |
| Fritz Erich A | EVP, Global Supply Chain | May 05 '26 | Option Exercise | 0.00 | 1,372 | 0 | 12,132 | May 07 |
| Fuller Kevin Gregory | Global Chief Marketing Officer | May 05 '26 | Option Exercise | 0.00 | 1,677 | 0 | 23,137 | May 07 |
| Herbert Kevin R. | EVP & President, North America | May 05 '26 | Option Exercise | 0.00 | 1,500 | 0 | 42,906 | May 07 |
| Jones Leslie Shane | EVP & Chief Financial Officer | May 05 '26 | Option Exercise | 0.00 | 6,488 | 0 | 105,748 | May 07 |
| Lanoy Jonathan David | SVP, Chief Accounting Officer | May 05 '26 | Option Exercise | 0.00 | 3,158 | 0 | 42,612 | May 07 |
| Norman Daniel C | EVP & President, Asia | May 05 '26 | Option Exercise | 0.00 | 7,288 | 0 | 46,225 | May 07 |